SPECIALLÆGERNE I PSYKIATRI LIEN OG GULDBÆK I/S

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  0.7% 0.7% 0.7% 0.7% 0.7%  
Bankruptcy risk  6.9% 5.9% 7.8% 14.4% 16.4%  
Credit score (0-100)  36 39 30 14 10  
Credit rating  BBB BBB BB BB BB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  2,655 2,188 2,465 2,729 4,539  
EBITDA  2,056 1,593 1,927 2,179 3,895  
EBIT  2,032 1,571 1,904 2,152 3,895  
Pre-tax profit (PTP)  2,032.7 1,578.6 1,903.2 2,151.4 3,912.6  
Net earnings  2,032.7 1,578.6 1,903.2 2,151.4 3,912.6  
Pre-tax profit without non-rec. items  2,033 1,579 1,903 2,151 3,913  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  24.9 50.6 27.5 0.0 0.0  
Shareholders equity total  551 490 549 608 1,635  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  796 844 765 798 1,894  

Net Debt  -35.7 -136 -62.8 -82.7 -1,115  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  2,655 2,188 2,465 2,729 4,539  
Gross profit growth  -0.5% -17.6% 12.6% 10.7% 66.3%  
Employees  1 1 1 1 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  796 844 765 798 1,894  
Balance sheet change%  -10.2% 5.9% -9.3% 4.4% 137.2%  
Added value  2,055.9 1,592.8 1,927.5 2,175.0 3,894.7  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -47 4 -46 -55 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 5.0 5.0 5.0 5.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  76.5% 71.8% 77.3% 78.8% 85.8%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  242.9% 193.2% 238.9% 277.8% 290.9%  
ROI %  335.0% 304.3% 369.8% 375.3% 349.1%  
ROE %  333.2% 303.3% 366.3% 371.9% 348.8%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  69.1% 58.1% 71.7% 76.2% 86.3%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -1.7% -8.5% -3.3% -3.8% -28.6%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  3.1 2.2 3.4 4.2 7.3  
Current Ratio  3.1 2.2 3.4 4.2 7.3  
Cash and cash equivalent  35.7 135.9 62.8 82.7 1,114.7  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  525.6 439.9 521.2 608.4 1,634.9  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  2,056 1,593 1,927 2,175 3,895  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  2,056 1,593 1,927 2,179 3,895  
EBIT / employee  2,032 1,571 1,904 2,152 3,895  
Net earnings / employee  2,033 1,579 1,903 2,151 3,913